CC312

CC312 · CytoCares Inc

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CC312, covering 2025-09-17 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CC312 for Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]